Table 5 Summary of crystallographic data for [Pb{2-(Ph2PO)-6-(Me3Si)C6H3S}2] 3, [Pb{2-(Ph2P(O)CH2)C6H4S}2] 4, [Pb{2-(Ph2P(S)CH2)C6H4S}2]
5 and [Pb{2,6-(Ph2P(S)CH2)2C6H3S}2] 6
3
4
5
6
Chemical formula
Formula weight
T/K
C42H44O2P2S2Si2Pb
970.20
150(2)
C38H32O2P2S2Pb
853.88
150(2)
C38H32P2S4Pb
886.01
150(2)
C64H54P4S6Pb
1346.52
293(2)
Crystal system
Space group
Monoclinic
P21/n
Monoclinic
Cc
Monoclinic
Cc
Monoclinic
Cc
a/Å
b/Å
c/Å
11.417(2)
24.1217(3)
15.8139(2)
106.6110(1)
4173.40(7)
4
14.6460(10)
15.5010(10)
15.4290(10)
99.583(2)
3453.9(4)
4
15.5560(10)
15.6120(10)
15.0520(10)
100.455(2)
3594.8(4)
4
16.212(3)
14.4198(10)
25.146(3)
92.014(14)
5874.9(14)
4
β/Њ
V/Å3
Z
µ/mmϪ1
4.311
5.131
5.041
3.234
Reflections collected
Independent reflections
Data/restraints/parameters
Ra
26969
9852
9852/0/455
0.0268
0.0608
6487
6712
5678
3674 (0.0367)
3674/2/420
0.0337
3804 (0.0342)
3804/68/369
0.0475
5678 (0.00)
5678/2/676
0.0362
b
wR2
0.852
0.1164
0.0849
a R = Σ(|Fo| Ϫ |Fc|)/Σ|Fo|. b wR2 = [(Σw(|Fo| Ϫ |Fc|)2/Σw|Fo|2]1/2
.
2-(Ph2P)-6-(Me3Si)C6H3SH in 50 cm3 of acetonitrile, dissolved
80 mg of lead, Ef = 0.52 mol FϪ1. As the reaction proceeds the
solution changed from colourless to yellow. At the end of the
electrolysis the yellow solid deposited in the cell was recovered,
washed with cool acetonitrile and diethyl ether and dried in
vacuo (0.30 g, 86%). Anal. Calc. for C42H44PbP2S2Si2: C, 53.8;
H, 4.7; S, 6.8. Found: C, 53.6; H, 4.6; S, 6.4%. IR (KBr, cmϪ1):
3053m, 2949m, 2893m, 1554m, 1483m, 1434m, 1355s, 1245m,
1086m, 850s, 746s, 692s, 530s. 1H NMR (CDCl3): δ 7.7–6.6 (m,
26 H), 0.30 (s, 18H). 31P NMR (CDCl3): δ 41.6.
scopy and elemental analysis. Anal. Calc. for C38H32P2S4Pb: C,
51.5; H, 3.6; S, 14.5. Found: C, 50.7; H, 3.0; S, 14.2%. IR (KBr,
cmϪ1) 3052m, 2898m, 1582m, 1462w, 1435m, 1104s, 830m,
1
747m, 699s, 599m. H NMR (CDCl3): δ 7.9 (complex m, 8H),
7.8 (m, 2H), 7.5 (m, 10H), 7.4 (m, 2H), 7.1 (t, 2H), 6.7 (t, 2H),
6.5 (d, 2H), 4.65 (d, JPH = 12.4 Hz, CH2P, 4H). 13C NMR
(CDCl3): δ 142–126, 39.7 (d, JPC = 51.7 Hz, CH2P). 31P NMR
(CDCl3): δ 40.5.
[Pb{2,6-(Ph2P(S)CH2)2C6H3S}2] 6. To a methanol solution of
2,6-(Ph2P(S)CH2)2C6H3SH (0.33 g, 0.588 mmol) was added 0.1
g (0.29 mmol) of lead acetate. The mixture was stirred for 4 h,
the yellow solid formed was filtered off, and washed with
methanol and diethyl ether. Yield 0.28 g (72%). Anal. Calc. for
C64H54P4S6Pb: C, 57.1; H, 4.0; S, 14.3. Found: C, 56.4; H, 4.2;
S, 13.6%. 1H NMR (CDCl3): δ 7.9–6.8 (m, Ph, 23H), 3.69
(d, JPH = 13.3 Hz, CH2P, 4H). 31P NMR (CDCl3): δ 40.2, 36.6.
[Pb{2-(Ph2PO)-6-(Me3Si)C6H3S}2] 3. Electrolysis of an
acetonitrile solution (50 cm3) containing 2-(Ph2PO)-6-(Me3Si)-
C6H3SH (0.214 g, 0.560 mmol) using a current of 10 mA, (12 V)
for 1.5 h caused the dissolution of 58 mg of lead (Ef = 0.50 mol
F
Ϫ1) to produce a yellow crystalline solid. The solid was washed
with acetonitrile and diethyl ether and dried in vacuo (0.22 g,
82%). Anal. Calc. for C42H44PbP2O2S2Si2: C, 52.0; H, 4.5; S, 6.6.
Found: C, 51.2; H, 4.3; S, 6.5%. IR (KBr, cmϪ1): 3055m, 2952m,
2895m, 1556m, 1438s, 1353s, 1242s, 1130s, 1065m, 845s, 748s,
X-Ray crystal structure determinations
Data collection. Intensity data were collected on a CAD4
diffractometer for compound 3 and on an Enraf-Nonius
DIP2000 image-plate diffractometer for 4–6, with mono-
chromated Mo-Kα radiation (λ = 0.71073 Å) in all cases. The
images were processed with the Denzo and Scalepak programs
for the latter compounds.20
1
692s. H NMR (CDCl3): δ 7.7–6.7 (m, 26H), 0.40 (s, 18H). 31P
(CDCl3): δ 52.8. Crystals suitable for X-ray studies were
obtained by crystallisation from CH2Cl2–MeOH.
[Pb{2-(Ph2P(O)CH2)C6H4S}2] 4. To a solution of 2-(Ph2P-
(O)CH2)C6H4SH (0.10 g, 0.31 mmol) in 20 ml of methanol
was added a solution of lead acetate (0.05 g, 0.154 mmol) in
methanol (15 ml). The solution was stirred at room temperature
for 2 h to give a bright yellow solid, which was filtered off,
washed with methanol, diethyl ether and dried in vacuo (0.105
g, 81%). Crystals suitable for X-ray studies were obtained by
crystallisation from CH2Cl2–diethyl ether and identified by
spectroscopy and elemental analysis. Anal. Calc. for C38H32P2-
S2O2Pb: C, 53.4; H, 3.7; S, 7.5. Found: C, 52.0; H, 3.24; S, 6.7%.
IR (KBr, cmϪ1) 3053m, 2920m, 1582m, 1462m, 1436m, 1383m,
Structure analysis and refinement. The structures were solved
2
via direct methods21 and refined on Fo by full-matrix least-
squares methods.22 All non-hydrogen atoms were refined
anisotropically. The hydrogen atoms were included in idealised
positions with Uiso free to refine. The weighting scheme gave
satisfactorily agreement analysis. Sources of scattering factors
were as in ref. 18. Details of the structure determination are
listed in Table 5.
CCDC reference number 186/1802.
lographic files in .cif format.
1
1225w, 1136s, 1094m, 835s, 749m, 722s, 629m, 534s. H NMR
(CDCl3): δ 7.85 (t, 8H), 7.55 (m, 14H), 7.05 (t, 2H), 6.7 (t, 2H),
6.5 (t, 2H), 4.35 (d, JPH = 12.6 Hz, CH2P, 4H). 13C NMR
(CDCl3): δ 141–125, 36.6 (d, JPC = 57.5 Hz, CH2P). 31P NMR
(CDCl3): δ 27.5.
Acknowledgements
We thank the Xunta de Galicia (Spain), (Xuga 20910B93 and
Xuga 20316B96), for financial support.
[Pb{2-(Ph2P(S)CH2)C6H4S}2] 5. The same procedure as for 4
was used for the synthesis of this compound. A solution of lead
acetate (0.20 g, 0.588 mmol) in 25 ml of methanol was added to
2-(Ph2P(S)CH2)C6H4SH (0.094 g, 0.290 mmol), in 20 ml of
methanol. It was stirred for 2 h to give a yellow solid (0.23 g,
89%). Crystals suitable for X-ray studies were obtained by
crystallisation from CH2Cl2–MeOH and identified by spectro-
References
1 M. M. Jones, Met. Ions Biol. Syst., 1983, 16, 47.
2 J. J. I. Arsenault and P. A. W. Dean, Can. J. Chem., 1983, 61, 1516
and references therein.
J. Chem. Soc., Dalton Trans., 2000, 769–774
773